Friday 27 June, 2008
Tuesday 24 June, 2008
The C.S.(G) Vaccine
P.S. No hard feelings....(If u ever read this)
In today's new era, we are proud to announce that we have found a vaccine to attain immunity to C.S.'s barrage of infinite gibberish @ public places. (Read: Henceforth called "The C.S. Virus")
Introduction:
The C.S. Vaccine is a live non-attenuated virus, administered via "live interaction" for immunization against the C.S. Virus. It is generally administered to friends of C.S. who wish to become immune.
In India, the vaccine has been licensed for use from 12 Dec 2007.
It is widely used since introduction of its earliest versions. Over 500 doses have been used in over 2000 students of BJMC, Pune. As with all vaccinations, long-term effects and efficacy are subject to continuing study.
The vaccine is sold by FCS Group as CSV-II currently. We are the whole and sole copyright owners of this vaccine.
Dosage Schedule:
First Dose: The first interaction with C.S.
Second Dose: One year on........
The second dose is not a booster; it is a dose to produce immunity in the large number of people (92-96%) who fail to develop immunity after the first dose.
Booster Dosages: At all parties at public places.
Effectiveness:
Following the primary course of 2 vaccinations, a test may be taken at any public place meet to establish if there has been an adequate response, which is defined as ability to stay calm, quiet, non-irritant after being exposed to 30 min of the C.S. Virus. Such a full response occurs in about 3% of individuals.
A response of anger, shouting, acts like putting ones fingers into one's ears, embarrassment in the presence of the C.S.Virus is considered a poor response, and these people should receive a single booster vaccination at this time.
People who fail to respond should be tested to exclude genetic/behavioral mutations resembling the C.S.Virus. Such people need not take another dose of the vaccine as irreparable damage has already occurred in them.
Poor responses are mostly associated with late life exposure to the C.S.Virus, genetic mutations resembling the C.S.Virus.
Although initially it was thought that there is no protection offered by the vaccine, it has now been found that the vaccine can provide some protection lasting from 12 days to 12 weeks in a small subset of the population.
References:
1. The Center for Prevention and Control, USA- Factsheet No 121212/2008 timed 12:12:12 am. (CST)
2. The Joint Committee on Vaccination(2007-2008), FCS Group, Pune.
3. DSS, ISA, PAS in their original article : "Immune responses to the C.S.Vaccine."
